Nathan D. Jorgensen Vor Biopharma Inc. (VOR) insider trading activity

Nathan D. Jorgensen is CHIEF FINANCIAL OFFICER of Vor Biopharma Inc.. Currently has a direct ownership of 189,403 shares of VOR, which is worth approximately $189,403. The most recent transaction as insider was on May 06, 2024, when has been sold 834 shares (Common Stock) at a price of $1.75 per share, resulting in proceeds of $1,459. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 189K

0.92% 3M change

23.29% 12M change

Total Value Held $189,403

Nathan D. Jorgensen Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 06 2024	SELL Payment of exercise price or tax liability	$1,459 $1.75 p/Share	834 Reduced 0.44%	189,403 Common Stock
May 01 2024	SELL Payment of exercise price or tax liability	$1,623 $1.77 p/Share	917 Reduced 0.48%	190,237 Common Stock
Mar 01 2024	SELL Payment of exercise price or tax liability	$14,323 $2.27 p/Share	6,310 Reduced 3.2%	191,154 Common Stock
Feb 06 2024	SELL Payment of exercise price or tax liability	$2,285 $2.32 p/Share	985 Reduced 0.5%	197,464 Common Stock
Jan 29 2024	BUY Grant, award, or other acquisition	-	50,000 Added 20.12%	198,449 Common Stock
Nov 06 2023	SELL Payment of exercise price or tax liability	$1,517 $1.82 p/Share	834 Reduced 0.57%	145,647 Common Stock
Sep 01 2023	SELL Payment of exercise price or tax liability	$16,847 $2.67 p/Share	6,310 Reduced 4.13%	146,481 Common Stock

Aug 07 2023	SELL Payment of exercise price or tax liability	$2,226 $2.67 p/Share	834 Reduced 0.54%	152,791 Common Stock
May 08 2023	SELL Payment of exercise price or tax liability	$3,452 $4.14 p/Share	834 Reduced 0.54%	153,625 Common Stock
Mar 01 2023	SELL Payment of exercise price or tax liability	$34,768 $5.51 p/Share	6,310 Reduced 3.92%	154,459 Common Stock
Feb 06 2023	BUY Grant, award, or other acquisition	-	45,500 Added 22.06%	160,769 Common Stock
Sep 01 2022	BUY Grant, award, or other acquisition	-	86,000 Added 42.73%	115,269 Common Stock
Feb 09 2021	BUY Conversion of derivative security	-	3,534 Added 10.77%	29,269 Common Stock

NDJ

Nathan D. Jorgensen

CHIEF FINANCIAL OFFICER

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VOR shares.

Notify only if

Value

Insider Trading

Get notified when an Vor Biopharma Inc. insider buys or sells VOR shares.

Notify only if

Operation

Value

Type

News

Receive news related to Vor Biopharma Inc.

Track Activities on VOR

Account